FCM
NITE

Farallon Capital Management’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Farallon Capital Management’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-40,300
Closed -$774K – 94
2017
Q3 		$774K Buy
+40,300
New +$870K 0.01% 85

Other funds holding NITE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Farallon Capital Management's NITE Position: Q4 2017 in Review

Farallon Capital Management sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q4 2017, closing a stake of 40,300 shares — an estimated $774K sold.

Farallon Capital Management first reported a position in NITE in Q3 2017 and held it in 1 quarter. The position peaked at $774K in Q3 2017. 16 funds tracked by Wall St. Rank hold NITE as of Q4 2017.

  • Farallon Capital Management reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q4 2017 after selling out during the quarter.
  • Farallon Capital Management sold 40,300 Nightstar Therapeutics plc American Depositary Shares shares in Q4 2017, an estimated $774K.
  • Farallon Capital Management first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2017 and held it in 1 quarter.
  • Farallon Capital Management's Nightstar Therapeutics plc American Depositary Shares position peaked at $774K in Q3 2017.
  • 16 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q4 2017.

Based on Farallon Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.